BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36103974)

  • 61. Obesity modifies bone marrow microenvironment and directs bone marrow mesenchymal cells to adipogenesis.
    da Silva SV; Renovato-Martins M; Ribeiro-Pereira C; Citelli M; Barja-Fidalgo C
    Obesity (Silver Spring); 2016 Dec; 24(12):2522-2532. PubMed ID: 27753270
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pioglitazone improves insulin secretory capacity and prevents the loss of beta-cell mass in obese diabetic db/db mice: Possible protection of beta cells from oxidative stress.
    Ishida H; Takizawa M; Ozawa S; Nakamichi Y; Yamaguchi S; Katsuta H; Tanaka T; Maruyama M; Katahira H; Yoshimoto K; Itagaki E; Nagamatsu S
    Metabolism; 2004 Apr; 53(4):488-94. PubMed ID: 15045697
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Co-culture of the bone and bone marrow: a novel way to obtain mesenchymal stem cells with enhanced osteogenic ability for fracture healing in SD rats.
    Zhu C; Sha M; Jiang H; Lin J; Lin W; Li W; Chen X; Huang G; Ding Z
    J Orthop Surg Res; 2019 Sep; 14(1):293. PubMed ID: 31481070
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The PPAR-gamma agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells.
    Gensch C; Clever YP; Werner C; Hanhoun M; Böhm M; Laufs U
    Atherosclerosis; 2007 May; 192(1):67-74. PubMed ID: 16876172
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cultured Human Periosteum-Derived Cells Can Differentiate into Osteoblasts in a Perioxisome Proliferator-Activated Receptor Gamma-Mediated Fashion via Bone Morphogenetic Protein signaling.
    Chung JE; Park JH; Yun JW; Kang YH; Park BW; Hwang SC; Cho YC; Sung IY; Woo DK; Byun JH
    Int J Med Sci; 2016; 13(11):806-818. PubMed ID: 27877072
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma.
    Foryst-Ludwig A; Clemenz M; Hohmann S; Hartge M; Sprang C; Frost N; Krikov M; Bhanot S; Barros R; Morani A; Gustafsson JA; Unger T; Kintscher U
    PLoS Genet; 2008 Jun; 4(6):e1000108. PubMed ID: 18584035
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Positive interaction between prebiotics and thiazolidinedione treatment on adiposity in diet-induced obese mice.
    Alligier M; Dewulf EM; Salazar N; Mairal A; Neyrinck AM; Cani PD; Langin D; Delzenne NM
    Obesity (Silver Spring); 2014 Jul; 22(7):1653-61. PubMed ID: 24585705
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Modulation of lipid mediator profile may contribute to amelioration of chronic inflammation in adipose tissue of obese mice by pioglitazone.
    Okada K; Hosooka T; Shinohara M; Ogawa W
    Biochem Biophys Res Commun; 2018 Oct; 505(1):29-35. PubMed ID: 30236987
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Subtherapeutic dose of pioglitazone reduces expression of inflammatory adipokines in db/db mice.
    Mohapatra J; Sharma M; Singh S; Chatterjee A; Swain P; Balaraman R; Patel PR; Jain MR
    Pharmacology; 2009; 84(4):203-10. PubMed ID: 19738399
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The thiazolidinedione pioglitazone increases cholesterol biosynthetic gene expression in primary cortical neurons by a PPARgamma-independent mechanism.
    Cocks G; Wilde JI; Graham SJ; Bousgouni V; Virley D; Lovestone S; Richardson J
    J Alzheimers Dis; 2010; 19(2):631-46. PubMed ID: 20110608
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pioglitazone inhibits the growth of human leukemia cell lines and primary leukemia cells while sparing normal hematopoietic stem cells.
    Saiki M; Hatta Y; Yamazaki T; Itoh T; Enomoto Y; Takeuchi J; Sawada U; Aizawa S; Horie T
    Int J Oncol; 2006 Aug; 29(2):437-43. PubMed ID: 16820887
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of pioglitazone versus diet and exercise on metabolic health and fat distribution in upper body obesity.
    Shadid S; Jensen MD
    Diabetes Care; 2003 Nov; 26(11):3148-52. PubMed ID: 14578253
    [TBL] [Abstract][Full Text] [Related]  

  • 73. S-nitrosoglutathione reductase-dependent PPARγ denitrosylation participates in MSC-derived adipogenesis and osteogenesis.
    Cao Y; Gomes SA; Rangel EB; Paulino EC; Fonseca TL; Li J; Teixeira MB; Gouveia CH; Bianco AC; Kapiloff MS; Balkan W; Hare JM
    J Clin Invest; 2015 Apr; 125(4):1679-91. PubMed ID: 25798618
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Replicative senescence of human bone marrow and umbilical cord derived mesenchymal stem cells and their differentiation to adipocytes and osteoblasts.
    Cheng H; Qiu L; Ma J; Zhang H; Cheng M; Li W; Zhao X; Liu K
    Mol Biol Rep; 2011 Nov; 38(8):5161-8. PubMed ID: 21188535
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pioglitazone treatment enlarges subcutaneous adipocytes in insulin-resistant patients.
    Koenen TB; Tack CJ; Kroese JM; Hermus AR; Sweep FC; van der Laak J; Stalenhoef AF; de Graaf J; van Tits LJ; Stienstra R
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4453-7. PubMed ID: 19820024
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Organotins are potent activators of PPARγ and adipocyte differentiation in bone marrow multipotent mesenchymal stromal cells.
    Yanik SC; Baker AH; Mann KK; Schlezinger JJ
    Toxicol Sci; 2011 Aug; 122(2):476-88. PubMed ID: 21622945
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Insulin Signaling in Bone Marrow Adipocytes.
    Tencerova M; Okla M; Kassem M
    Curr Osteoporos Rep; 2019 Dec; 17(6):446-454. PubMed ID: 31749085
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pioglitazone promotes survival and prevents hepatic regeneration failure after partial hepatectomy in obese and diabetic KK-A(y) mice.
    Aoyama T; Ikejima K; Kon K; Okumura K; Arai K; Watanabe S
    Hepatology; 2009 May; 49(5):1636-44. PubMed ID: 19205029
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pleiotropic effects of thiazolidinediones: implications for the treatment of patients with type 2 diabetes mellitus.
    Defronzo RA; Mehta RJ; Schnure JJ
    Hosp Pract (1995); 2013 Apr; 41(2):132-47. PubMed ID: 23680744
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Genetic inhibition of PPARγ S112 phosphorylation reduces bone formation and stimulates marrow adipogenesis.
    Ge C; Zhao G; Li B; Li Y; Cawthorn WP; MacDougald OA; Franceschi RT
    Bone; 2018 Feb; 107():1-9. PubMed ID: 29107124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.